Announcements Trials
Browse Landscape

Phase

Phase 2 102Phase 1 81Phase 1/2 42Phase NA 32Phase 3 30Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Completed 35Terminated 15Recruiting 12Withdrawn 7Unknown 6Not yet recruiting 6Active not recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 21Genitourinary 15Gastrointestinal 15Sarcoma 9Lymphoid 9Head & Neck 9Gynecologic 8Endocrine 8Breast 7Plasma cell 6Other solid neoplasm 5NET 5Thoracic 4Dermatologic 3Tumor-Agnostic 2Other hematologic neoplasm 2

Conditions

Melanoma 3Skin Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Motor Activity 1Lymphoma 1Head and Neck Neoplasms 1Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 2Nivolumab 2encorafenib 1cemiplimab 1binimetinib 1avelumab 1Ipilimumab 1Immune Checkpoint Inhibitors 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Dermatologic × Clear all
NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Presage Biosciences

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
14 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡